Pure Global
NCT05645068

Retinal Microvasculature by OCT Angiography During Integrating Physical Activity in Type 2 Diabetic Subjects.

Pilot Study for the Evaluation of Retinal Microvasculature by OCT Angiography During a Multidisciplinary Management Program Integrating Physical Activity in Type 2 Diabetic Subjects.
University Hospital, Toulouse·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Complications
Drug/Device/Intervention
Optical Coherence Tomography Angiography
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
University Hospital, Toulouse
Location
Toulouse, France
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2022
End date
Mar 01, 2024
Enrollment
30 participants
Primary outcome

coefficient of variation of the superficial retinal capillary plexus

Summary

Diabetic retinopathy is a common condition of diabetes and can lead to blindness, making it
 one of the most feared complications of diabetes.
 
 Recently, it has been proven that the parameters measured by Optical Coherence Tomography
 Angiography: the vascular density of the macular retinal capillary plexi and the foveolar
 avascular zone, can be modified after a high-intensity sports training program in healthy
 subjects.
 
 the team wants to study the evolution of the macular, in type 2 diabetic subjects, before and
 after a stay in a care structure dedicated to the multidisciplinary and integrative
 management (nutrition, physical activity, therapeutic education) of a duration of 3 weeks.

ICD-10 classifications
Unspecified diabetes mellitus without complicationsOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus without complicationsUnspecified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05645068
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05645068 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Toulouse and is currently Not yet recruiting. The study focuses on Diabetes Complications. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.